(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2.17% SEK 0.235
Live Chart Being Loaded With Signals
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis...
Stats | |
---|---|
Dzisiejszy wolumen | 71 781.00 |
Średni wolumen | 223 086 |
Kapitalizacja rynkowa | 6.81M |
EPS | SEK-0.100 ( 2023-11-22 ) |
Następna data zysków | ( SEK0 ) 2024-06-07 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.450 |
ATR14 | SEK0.0120 (5.11%) |
Lipidor AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lipidor AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK78 000.00 |
Zysk brutto: | SEK-15.46M (-19 824.36 %) |
EPS: | SEK-0.400 |
FY | 2023 |
Przychody: | SEK78 000.00 |
Zysk brutto: | SEK-15.46M (-19 824.36 %) |
EPS: | SEK-0.400 |
FY | 2022 |
Przychody: | SEK45 000.00 |
Zysk brutto: | SEK-41.72M (-92 704.44 %) |
EPS: | SEK-1.420 |
FY | 2021 |
Przychody: | SEK15.38M |
Zysk brutto: | SEK0.00 (0.00 %) |
EPS: | SEK-0.750 |
Financial Reports:
No articles found.
Lipidor AB (publ)
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej